Search research articles
Contact Us
Filters
Showing results (241-250 of 396) with videos related to
Page
of 40
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
May 13, 1997
The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
N Rouas-Freiss, R E Marchal, M Kirszenbaum, et al.
Tissue Antigens
|
August 1, 1987
HLA and non-HLA phenotyping and genotyping in Austral and Gambier Polynesian Archipelagos
C Dehay, B Gentile, M Jeannet, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|
January 1, 1974
[Secretion and absorption on O erythrocytes of the Atri substance]
A Marcelli-Barge, J C Poirier, A Benajam, et al.
Transplantation
|
June 1, 1980
Lymphocytotoxic antibodies after bone marrow transplantation in aplastic anemia. II. Non-HLA antibodies
E Gluckman, J C Gluckman, E Andersen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 23, 1997
Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
N Rouas-Freiss, R M Gonçalves, C Menier, et al.
Immunogenetics
|
January 1, 1981
Alloantigens expressed on activated human T cells different from HLA-A, B, C, and DR antigens
M Gerbase de Lima, E E Wollman, V Lepage, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1986
HLA-DR2, -DR5, and DRw6 associated Dw subtypes correlate with HLA-DR beta and -DQ beta restriction fragment length polymorphisms
M P Font, L Gebuhrer, H Betuel, et al.
Human Immunology
|
November 27, 1998
Specific binding of nuclear factors to the HLA-G gene promoter correlates with a lack of HLA-G transcripts in first trimester human fetal liver
P Moreau, S Lefebvre, L Gourand, et al.
Human Immunology
|
January 4, 2001
The X1 box of HLA-G promoter is a target site for RFX and Sp1 factors
P Rousseau, P Paul, M O'Brien, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1988
Use of a variable alpha region to create a functional T-cell receptor delta chain
P Guglielmi, F Davi, L d'Auriol, et al.
Page
of 40
Search research articles
Search
Showing results (241-250 of 396) with videos related to
Sort By:
Page
of 40
Proceedings of the National Academy of Sciences of the United States of America
|
May 13, 1997
The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
N Rouas-Freiss, R E Marchal, M Kirszenbaum, et al.
Tissue Antigens
|
August 1, 1987
HLA and non-HLA phenotyping and genotyping in Austral and Gambier Polynesian Archipelagos
C Dehay, B Gentile, M Jeannet, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|
January 1, 1974
[Secretion and absorption on O erythrocytes of the Atri substance]
A Marcelli-Barge, J C Poirier, A Benajam, et al.
Transplantation
|
June 1, 1980
Lymphocytotoxic antibodies after bone marrow transplantation in aplastic anemia. II. Non-HLA antibodies
E Gluckman, J C Gluckman, E Andersen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 23, 1997
Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
N Rouas-Freiss, R M Gonçalves, C Menier, et al.
Immunogenetics
|
January 1, 1981
Alloantigens expressed on activated human T cells different from HLA-A, B, C, and DR antigens
M Gerbase de Lima, E E Wollman, V Lepage, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1986
HLA-DR2, -DR5, and DRw6 associated Dw subtypes correlate with HLA-DR beta and -DQ beta restriction fragment length polymorphisms
M P Font, L Gebuhrer, H Betuel, et al.
Human Immunology
|
November 27, 1998
Specific binding of nuclear factors to the HLA-G gene promoter correlates with a lack of HLA-G transcripts in first trimester human fetal liver
P Moreau, S Lefebvre, L Gourand, et al.
Human Immunology
|
January 4, 2001
The X1 box of HLA-G promoter is a target site for RFX and Sp1 factors
P Rousseau, P Paul, M O'Brien, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1988
Use of a variable alpha region to create a functional T-cell receptor delta chain
P Guglielmi, F Davi, L d'Auriol, et al.
Page
of 40